Product Description
Since last manyyears SaintroyLifescienceis leading manufacture, export and supplierofGemcitabine for Injectionfrom Surat, Gujarat, India. Gemcitabine For Injection used as a first-line treatment alone for pancreatic cancer, and in combination with cisplatin for advanced or metastatic bladder cancer and advanced or metastatic non-small cell lung cancer.
Tags: Gemcitabine for Injection manufacturer, Gemcitabine forInjection exporter, Gemcitabine for Injection supplier, and Gemcitabine forInjection, whogmp approved Gemcitabine for Injection manufacturer and supplier,Gemcitabine for Injection distributor, Gemcitabine for Injection shipper, Gemcitabine ForInjection 1.4 g Gemcitabine for Injection 1.4 gsupplier,Gemcitabine for Injection1.4 g.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturingfacility in Gujarat, India.
Registration: Saintroy Lifescienceis interested inregistration of own brand or customer brands in ministryof health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country:Saintroy LifescienceGemcitabine forInjection export to USA, Canada, Germany, Europe, France, Ghana, Nigeria,Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile,Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia, HongKong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo,Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador,Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana,Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Comprehensive Cancer TherapyGemcitabine for Injection serves as a trusted choice for oncologists in delivering effective chemotherapy for a wide spectrum of cancers. By interfering with DNA synthesis in tumor cells, it slows cancer progression and can be incorporated into various treatment regimens. Its broad clinical application underscores its essential role in modern oncology.
Simple and Safe AdministrationThis medication is provided as a white to off-white lyophilized powder in single-dose clear glass vials. Reconstitution with sterile saline before intravenous infusion ensures precise dosing and convenient handling. Adherence to cytotoxic handling protocols is essential to ensure safety for healthcare professionals and patients alike.
Reliable Quality and ComplianceManufactured in compliance with USP standards, Gemcitabine for Injection offers consistency and high standards in every vial. Its storage and handling requirements, combined with clear labeling for prescription use only, make it suitable for distribution by dealers, exporters, and wholesalers throughout India and beyond.
FAQ's of Gemcitabine for Injection:
Q: How should Gemcitabine for Injection be reconstituted and administered?
A: Gemcitabine for Injection must be reconstituted with sterile saline as specifically directed in the product insert. Once fully dissolved, it is administered via intravenous infusion by a qualified healthcare provider. Proper handling precautions must be observed due to its cytotoxic nature.
Q: What are the recommended storage conditions for Gemcitabine for Injection vials?
A: Vials should be kept in a cool and dry place, avoiding direct sunlight or moisture, in order to preserve product stability. Follow shelf life recommendations, using within two years of the manufacturing date.
Q: When is Gemcitabine indicated for use in cancer treatment?
A: Gemcitabine is indicated for the treatment of pancreatic cancer, non-small cell lung cancer, breast cancer, ovarian cancer, and bladder cancer. Your oncologist will determine when it is appropriate to include Gemcitabine in your treatment regimen.
Q: Where can healthcare providers and distributors obtain Gemcitabine for Injection?
A: This medication is available through licensed dealers, distributors, exporters, manufacturers, suppliers, traders, and wholesalers across India, under prescription-only guidelines.
Q: What makes Gemcitabine an effective antimetabolite for cancer therapy?
A: Gemcitabine disrupts the replication of DNA in cancer cells, leading to cell death and helping slow tumor growth. Its mechanism as a nucleoside analogue has proven efficacy in a variety of solid tumors.
Q: What precautions should be taken while handling and administering Gemcitabine?
A: As a cytotoxic agent, adequate protective equipment should be used when reconstituting and administering the drug. Spillages and contamination must be avoided to ensure the safety of healthcare staff.
Q: What are the benefits of choosing this formulation of Gemcitabine for clinical or supply needs?
A: This product offers USP-compliant quality in a single-dose format, ensuring dosing accuracy, reliable efficacy, and a manageable shelf life, making it a sound option for hospitals, clinics, and supply chains.